A. Wong

Capecitabine as Adjuvant Treatment for Stage III Colon Cancer

Chris Twelves, A. Wong, Marek P. Nowacki et al. · New England Journal of Medicine · 2005 · 1.2K citations · Full text

Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study

Paulo M. Hoff, Rafat Ansari, Gerald Batist et al. · Journal of Clinical Oncology · 2001 · 1.1K citations

A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma.

Charles Erlichman, Shai Fine, A. Wong et al. · Journal of Clinical Oncology · 1988 · 505 citations

Surgical Oncology, Gastroenterology, Pathology +16

Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial

Werner Scheithauer, J McKendrick, S. Begbie et al. · Annals of Oncology · 2003 · 272 citations · Full text

Gastrointestinal Oncology, Oral Capecitabine, Medicine +8

Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy

Chris Twelves, Werner Scheithauer, J. McKendrick et al. · Annals of Oncology · 2011 · 198 citations · Full text